QIAGEN powered by

New study finds QCI Interpret One outperforms human NGS somatic variant interpretation

Press Releases

QDI and ATCC launch cell line database

QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, today announced the launch of their new cell line database developed through its partnership with ATCC, the leading biological materials organization, developer and supplier of authenticated cell lines.

QCI outperforms human variant interpretation

An externally facilitated clinical NGS interpretation validation study published in the Journal of Molecular Pathology demonstrates how QCI Interpret One achieves a higher level of concordance with a panel of experts than human reviewers achieve amongst each other.

QCI surpasses three million NGS patient test cases

QIAGEN announced that its decision-support software platform QIAGEN Clinical Insights (QCI) has been used to interpret more than three million patient molecular profiles for hereditary and oncological diseases to date.

QIAGEN Biomedical Knowledge Base

QIAGEN gives drug research direct access to world-leading data with launch of QIAGEN Biomedical Knowledge Base, supporting data science applications in pharmaceuticals and biotechnology that are becoming ever more important for drug discovery.

NHS England selects HGMD Professional for NGS Testing

NHS England and NHS Improvement will use QIAGEN’s HGMD Online Professional to support scientists and clinician across its network of 7 NHS Laboratory Hubs with clinical reporting and interpretation of genomic data.

QIAGEN launches new Digital Partner Program

QIAGEN today announced the launch of the QIAGEN Digital Insights Partnership program for genomic vendors to leverage QIAGEN’s genomic content and analysis leadership to expand customer access and deliver extended genomic solutions for scientists and clinicians.